Allogene Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Allogene Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $22M | 6.9M | 3.21 |
| 2023-09-30 | $22M | 6.9M | 3.17 |
| 2023-06-30 | $31M | 6.1M | 4.97 |
| 2023-03-31 | $25M | 4.9M | 5.04 |
| 2022-12-31 | $24M | 3.8M | 6.29 |
| 2022-06-30 | $83M | 4.5M | 18.52 |
| 2022-03-31 | $26M | 3.6M | 7.38 |
| 2021-12-31 | $59M | 3.6M | 16.39 |
| 2021-03-31 | $84M | 2.4M | 35.30 |
| 2020-12-31 | $49M | 2.0M | 25.24 |
| 2020-09-30 | $64M | 1.7M | 37.72 |
| 2020-06-30 | $60M | 1.4M | 42.82 |
| 2020-03-31 | $9.5M | 388k | 24.39 |
| 2019-12-31 | $2.1M | 84k | 24.39 |
| 2019-09-30 | $348k | 13k | 27.29 |
| 2019-06-30 | $285k | 11k | 26.66 |
| 2019-03-31 | $132k | 5.4k | 24.39 |
| 2018-12-31 | $134k | 5.5k | 24.39 |